Hastim Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • 2ndary - Private

Hastim General Information

Description

Developer of alternative medicine designed to treat and cure cancer. The company's anticancer treatments focus on strengthening of immune defenses of patients by using nanoparticle and biotechnology methods, enabling doctors to reduce the pain of patients suffering from cancer and attempt to cure cancer.

Contact Information

Website
www.hastim.fr
Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • Aeroparc Saint Martin
  • 12 rue de Caulet. Bâtiment A06
  • 31300 Toulouse
  • France
+33 05
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Nanotechnology, Life Sciences, Oncology
Corporate Office
  • Aeroparc Saint Martin
  • 12 rue de Caulet. Bâtiment A06
  • 31300 Toulouse
  • France
+33 05

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hastim Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-Sep-2023 Completed Generating Revenue
4. Angel (individual) 17-Jul-2013 Completed Generating Revenue
3. Angel (individual) 09-Dec-2010 Completed Generating Revenue
2. Product Crowdfunding 01-Jun-2010 $1M Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Hastim’s complete valuation and funding history, request access »

Hastim Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
To view Hastim’s complete cap table history, request access »

Hastim Patents

  • 38

    Total Documents Applications and Grants

  • Total Patents Families

  • 18

    Granted

  • 8

    Pending

  • Expiring in next 12 mo

Hastim Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4124663-A1 Methods for predicting a response to cancer treatment Inactive 29-Jul-2021
US-20210008187-A1 Autologous cancer vaccines Active 14-Mar-2018
EP-3765067-A1 Autologous cancer vaccines Pending 14-Mar-2018
CA-3093576-A1 Autologous cancer vaccines Pending 14-Mar-2018
AU-2019235488-A1 Autologous cancer vaccines Pending 14-Mar-2018 A61K39/0011
To view Hastim’s complete patent history, request access »

Hastim Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Hastim FAQs

  • When was Hastim founded?

    Hastim was founded in 2003.

  • Where is Hastim headquartered?

    Hastim is headquartered in Toulouse, France.

  • What is the size of Hastim?

    Hastim has 8 total employees.

  • What industry is Hastim in?

    Hastim’s primary industry is Drug Discovery.

  • Is Hastim a private or public company?

    Hastim is a Private company.

  • What is Hastim’s current revenue?

    The current revenue for Hastim is .

  • How much funding has Hastim raised over time?

    Hastim has raised $1.44M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »